Augusta Life Sciences International
Augusta Life Sciences International is younger than twelve months; there is no public track record yet to compute a bankruptcy probability from. The company has been active since 2025 and the Belgian State Gazette contains no insolvency signals. The CBE does carry 1 administrative register entry (see administrative flags). No processed annual-account figures are available; this conclusion rests on registry and State Gazette data only.
| Active | 0 yrs |
| Locations | 1 |
| Publications | 5 |
This company is younger than 12 months. There is no public track record yet to base a reliable estimate on, so we'd rather not show a number.
| NACE primary | Groothandel in farmaceutische en medische artikelen(46460) |
| Legal form | Private limited company(610) |
| Incorporation | 13-10-2025 |
| Status | Active |
| Postal code | 9320 |
Parcels linked to this company through its CBE addresses (seat, establishment units, branches), cross-referenced with the cadastral parcel plan. This shows where the company operates, not a deeds register.
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 41342B0624/00K000 | Flanders | 1.9 ha | 1 · 100 m² | - |
A single timeline of everything that happened to this company, publications, insolvency and lifecycle events, administrative changes and filed annual accounts.
We know of 6 Belgian State Gazette acts for this company. None of them has been read yet: what they contain is neither established nor disproved here.
29-05-2026 Change in the board of directors
Technical details
{
"events": [],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "1029.079.829",
"name_full": "AUGUSTA LIFE SCIENCES INTERNATIONAL",
"legal_form": "BV"
}
}23-02-2026 Change in the board of directors
Technical details
{
"events": [],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "1029.079.829",
"name_full": "AUGUSTA LIFE SCIENCES INTERNATIONAL",
"legal_form": "BV"
}
}26-01-2026 Capital increase of €42,386,000
Technical details
{
"events": [
{
"kind": "capital_increase",
"amount": 42386000.0,
"currency": "EUR",
"after_eur": null,
"delta_eur": 42386000.0,
"before_eur": null,
"amount_type": "kapitaal_effectief",
"effective_date": "2026-01-01",
"evidence_quote": "De vergadering beslist, met ingang van 1 januari 2026, het eigen vermogen te verhogen ten belope van 42.386.000,00 EUR, en beslist dat deze bijkomende inbreng zal verwezenlijkt worden door een inbreng in geld",
"contribution_type": "cash"
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "1029.079.829",
"name_full": "AUGUSTA LIFE SCIENCES INTERNATIONAL",
"legal_form": "BV"
}
}15-10-2025 Incorporation of a new BV
Technical details
{
"kind": "oprichting",
"seat": "Erembodegem-Dorp 86, 9320 Erembodegem",
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"founders": [
{
"org": {
"kbo": "0443.774.010",
"name": "BECTON DICKINSON B.V."
},
"kind": "rechtspersoon",
"person": null,
"share_class": "naam",
"partner_role": null,
"holder_org_kbo": "0443.774.010",
"holder_org_name": "BECTON DICKINSON B.V.",
"contribution_type": "cash",
"amount_paid_in_eur": 0,
"holder_person_name": null,
"is_subscriber_only": true,
"n_shares_subscribed": 1,
"amount_subscribed_eur": 1,
"is_anonymous_silent_partner": false
}
],
"capital_eur": 1,
"subject_company": {
"kbo": "1029.079.829",
"name_full": "Augusta Life Sciences International",
"legal_form": "BV"
},
"initial_directors": [],
"incorporation_date": "2025-10-08",
"post_incorporation_mandates": []
}| Legal nameNL | Augusta Life Sciences International |
- 07-07-2026 UBO non-compliance